TRP64ARG β3-adrenergic receptor and obesity in Mexican Americans

Human Genetics

Volumn 101, Issue 3, 1997, Pages 306-311

  Silver, Kristi ^a,e   Mitchell, Braxton D ^b   Walston, Jeremy ^a   Sorkin, John D ^c,e   Stern, Michael P ^d   Roth, Jesse ^a   Shuldiner, Alan R ^a,e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; INSULIN;

ADULT; AMINO ACID SUBSTITUTION; ANTHROPOMETRY; ARTICLE; BODY MASS; DIASTOLIC BLOOD PRESSURE; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ONSET AGE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN VARIANT; RECEPTOR GENE;

ARGININE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENOTYPE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MEXICAN AMERICANS; MIDDLE AGED; MUTATION; OBESITY; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-3; SYNDROME; TEXAS; TRYPTOPHAN;

EID: 0031432923     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050633     Document Type: Article

References (38)

1. Awata T, Kaayama S (1996) Genetic variation in the β3-adrenergic receptor in Japanese NIDDM patients. Diabetes Care 19: 271-272
2. Boerwinkle E, Chakraborty R, Sing CF (1986) The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytic methods. Ann Hum Genet 50:181-194
3. Bouchard C, Despres J, Tremblay A (1991) Genetics of obesity and human energy metabolism. Proc Nutr Soc 50:139-147
4. Candelore MR, Deng L, Tola LM, et al (1996) Pharmacological characterization of a recently described human β3-adrenergic receptor mutant. Endocrinology 137:2638-2641
5. Clement K, Vaisse C, Manning B, et al (1995) Genetic variation in the β3-adrenergic receptor and increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333:352-354
6. Cox NM, Bell GI (1989) Disease associations. Chance, artifact, or susceptibility genes? Diabetes 38:947-950
7. Elbein SC, Hoffman M, Bragg K, et al (1996) Beta-3-adrenergic receptor in obesity and non-insulin dependent diabetes among members of Caucasian families with a diabetic sibling pair. J Clin Endocrinol Metab 81:4422-4427
8. Fujisawa T, Ikegami H, Yamato E, et al (1996a) Association of Trp64Arg mutation of the β3-adrenergic receptor with NIDDM and body weight gain. Diabetologia 39:349-352
9. Fujisawa T, Ikegami H, Kawaguchi Y, Ogihara T (1996b) Response from the authors. Association of Trp64Arg mutation of the β3-adrenergic receptor with NIDDM and weight gain. Diabetologia 39:1412
10. Gagnon J, Mauriege P, Roy S, et al (1996) The Trp64Arg mutation of the beta-3-adrenergic receptor gene has no effect on obesity phenotypes in The Quebec Family Study and Swedish Obese Subjects cohorts. J Clin Invest 98:2086-2093
11. Haffner SM, Hazuda HP, Mitchell BD, et al (1991) Increased incidence of type II diabetes mellitus in Mexican Americans. Diabetes Care 14:102-108
12. Kadowaki H, Yasuda K, Iwamoto K, et al (1995) A mutation of the β3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 215:555-560
13. Keen RW, Samaras K, Woodford Richens KL, et al (1997) β3-adrenergic receptor gene polymorphisms and determination of adiposity and fat distribution in normal female twins. Diabetologia 40:122-123
14. Kim-Motoyama H, Yasuda K, Yamaguch T, et al (1997) A mutation of the β3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride. Diabetologia 40:469-472
15. Knowler WC (1996) Association of Trp64Arg mutation of the β3adrenergic receptor gene with NIDDM. Diabetologia 39:1411
16. Kurabayashi T, Carey DGP, Morrison NA (1996) The β3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women: effects on weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population. Diabetes 45:1358-1363
17. Li LS, Lonnqvist F, Luthman H, Arner P (1996) Phenotypic characterization of the Trp64Arg polymorphism in the β3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia 39:857-860
18. Lukens JN (1993) Hemoglobinopathies S, C, D, E, and O and associated diseases. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN (eds) Wintrobe's clinical hematology. Lea and Febiger, Philadelphia, pp 1076-1077
19. Mitchell BD, Kammerer CM, Reinhart LJ, Stern MP (1994) NIDDM in Mexican American families: heterogeneity by age of onset. Diabetes Care 17:567-573
20. Nagase T, Aoki A, Yamamoto M, et al (1997) Lack of association between Trp64Arg mutation in the β3-adrenergic receptor gene and obesity in Japanese men: a longitudinal analysis. J Clin Endocrinol Metab 82:1284-1287
21. Reaven GM (1989) Role of insulin resistance in human disease. Banting Lecture. Diabetes 37:1595-1607
22. Revelli J-P, Muzzin P, Paoloni A, et al (1993) Expression of the β3-adrenergic receptor in white adipose tissue. J Mol Endocrinol 10:193-197
23. Risen N, Merikangas K (1996) The future of genetic studies of complex human diseases. Science 273:1516-1517
24. Rotter JL, Vadheim CM, Rimoin DL (1990) Genetics of diabetes mellitus. In: Rifkin H, Porte D Jr (eds) Diabetes mellitus: theory and practice. Elsevier, Amsterdam, pp 378-413
25. Rouxel-Pietri F, Manning BSJ, Gros J, Strosberg AD (1997) The biochemical effect of the naturally occurring Trp64 → Arg mutation on the human β3-adrenoceptor activity. Eur J Biochem (in press)
26. Sakane N, Yoshida T, Yoshioka K, et al (1996) Genetic variation in β3-adrenergic receptor in Japanese NIDDM Patients. Diabetes Care 19:1034-1035
27. Shafrir E (ed) (1993) Frontiers in diabetes research: lessons from animal diabetes, IV. Smith-Gordon, London
28. Silver K, Walston, Wang Y, et al. (1996) Molecular scanning for mutations in the β3-adrenergic receptor gene in Nauruans with obesity and non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81:4155-4158
29. Susulic VS, Frederich FC, Lawitts J, et al (1995) Targeted disruption of the β3-adrenergic receptor gene. J Biol Chem 270: 29483-29492
30. Tataranni PA, Pratley R, Shuldiner A, Ravussin E (1997) β3-Adrenergic receptor gene variant and lipid metabolism in Pima Indians. Diabetologia 40:123-124
31. The Cystic Fibrosis Genotype-Phenotype Consortium (1993) Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 329:1308-1313
32. Urhammer SA, Clausen JO, Hansen T, Pedersen O (1996) Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the β3-adrenergic receptor gene. Diabetes 45:1115-1130
33. Van Duijn CM, Knijff P de, Cruts M, et al (1994) Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 7:74-78
34. Walston J, Silver K, Bogardus C, et al (1995) Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β3-adrenergic receptor gene. N Engl J Med 333:343-347
35. Widen E, Lehto M, Kannen T, et al (1995) Association of a polymorphism in the β3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333: 348-351
36. World Health Organization (1980) WHO expert committee on diabetes mellitus. Second report. (Technical Report Series no. 646) World Health Organization, Geneva
37. Yoshida T, Sakane N, Umekawa T, et al (1995) Mutations of β3adrenergic receptor gene and response to treatment of obesity. Lancet 346:1433-1434
38. Zhang Y, Wat N, Sttratton IM, et al (1996) UKPDS 19: heterogeneity in NIDDM; separate contributions of IRS-1 and beta-3-adrenergic receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Diabetes Study. Diabetologia 39:1505-1511